Ovarian Blood Sampling Identifies Junction Plakoglobin as a Novel Biomarker of Early Ovarian Cancer

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Search: onr:"swepub:oai:gup.ub.gu.se/302829" > Ovarian Blood Sampl...

1 of 1
Previous record
Next record
To hitlist

Details
MARC

Weiland, F. (author)

Ovarian Blood Sampling Identifies Junction Plakoglobin as a Novel Biomarker of Early Ovarian Cancer

Article/chapterEnglish2020

Publisher, publication year, extent ...

2020-09-25
Frontiers Media SA,2020

Numbers

LIBRIS-ID:oai:gup.ub.gu.se/302829
https://gup.ub.gu.se/publication/302829URI
https://doi.org/10.3389/fonc.2020.01767DOI

Supplementary language notes

Language:English

Part of subdatabase

SwePubSwePub

Classification

Subject category:ref swepub-contenttype
Subject category:art swepub-publicationtype

Notes

Ovarian cancer is the most lethal gynecologic malignancy. Early detection would improve survival, but an effective diagnostic test does not exist. Novel biomarkers for early ovarian cancer diagnosis are therefore warranted. We performed intraoperative blood sampling from ovarian veins of stage I epithelial ovarian carcinomas and analyzed the serum proteome. Junction plakoglobin (JUP) was found to be elevated in venous blood from ovaries with malignancies when compared to those with benign disease. Peripheral plasma JUP levels were validated by ELISA in a multicenter international patient cohort. JUP was significantly increased in FIGO serous stage IA+B (1.97-fold increase; p < 0.001; n = 20), serous stage I (2.09-fold increase; p < 0.0001; n = 40), serous stage II (1.81-fold increase, p < 0.001, n = 23) and serous stage III ovarian carcinomas (1.98-fold increase; p < 0.0001; n = 34) vs. normal controls (n = 109). JUP plasma levels were not increased in early stage breast cancer (p = 0.122; n = 12). In serous ovarian cancer patients, JUP had a sensitivity of 85% in stage IA+B and 60% in stage IA-C, with specificities of 76 and 94%, respectively. A logistic regression model of JUP and Cancer Antigen 125 (CA125) revealed a sensitivity of 70% for stage IA+B and 75% for stage IA-C serous carcinomas at 100% specificity. Our novel ovarian blood sampling – proteomics approach identified JUP as a promising new biomarker for epithelial ovarian cancer, which in combination with CA125 might fulfill the test criteria for ovarian cancer screening. © Copyright © 2020 Weiland, Lokman, Klingler-Hoffmann, Jobling, Stephens, Sundfeldt, Hoffmann and Oehler.

Subject headings and genre

MEDICIN OCH HÄLSOVETENSKAP Klinisk medicin Reproduktionsmedicin och gynekologi hsv//swe
MEDICAL AND HEALTH SCIENCES Clinical Medicine Obstetrics, Gynaecology and Reproductive Medicine hsv//eng
MEDICIN OCH HÄLSOVETENSKAP Klinisk medicin Cancer och onkologi hsv//swe
MEDICAL AND HEALTH SCIENCES Clinical Medicine Cancer and Oncology hsv//eng
abundance protein depletion
biomarker
early diagnosis
junction plakoglobin
mass spectrometry
ovarian cancer
proteomics
saturation labeling 2D-DIGE
biological marker
plakoglobin
adult
Article
biotinylation
blood sampling
cancer diagnosis
cancer screening
cancer staging
clear cell carcinoma
controlled study
endometrioid carcinoma
enzyme linked immunosorbent assay
female
human
image analysis
liquid chromatography-mass spectrometry
major clinical study
matrix assisted laser desorption ionization time of flight mass spectrometry
middle aged
ovary cancer
ovary cyst
prevalence
prospective study
protein analysis
tandem mass spectrometry
two dimensional difference gel electrophoresis

Added entries (persons, corporate bodies, meetings, titles ...)

Lokman, N. A. (author)
Klingler-Hoffmann, M. (author)
Jobling, T. (author)
Stephens, A. N. (author)
Sundfeldt, Karin,1962Gothenburg University,Göteborgs universitet,Sahlgrenska Cancer Center,Institutionen för kliniska vetenskaper, Avdelningen för obstetrik och gynekologi,Institute of Clinical Sciences, Department of Obstetrics and Gynecology(Swepub:gu)xsukar (author)
Hoffmann, P. (author)
Oehler, M. K. (author)
Göteborgs universitetSahlgrenska Cancer Center (creator_code:org_t)

Related titles

In:Frontiers in Oncology: Frontiers Media SA102234-943X

Internet link

Find in a library

Frontiers in Oncology (Search for host publication in LIBRIS)

To the university's database

1 of 1
Previous record
Next record
To hitlist

Find more in SwePub

By the author/editor: Weiland, F.; Lokman, N. A.; Klingler-Hoffman ...; Jobling, T.; Stephens, A. N.; Sundfeldt, Karin ...; show more...; Hoffmann, P.; Oehler, M. K.; show less...

About the subject

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Clinical Medicin ...; and Obstetrics Gynae ...

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Clinical Medicin ...; and Cancer and Oncol ...

Articles in the publication: Frontiers in Onc ...

By the university: University of Gothenburg

Search outside SwePub

Extend your search to:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se